January 19, 2018 / 10:06 PM / 10 months ago

Allergan loses bid to avoid Asacol antitrust trial after appellate order

Allergan PLC on Friday lost a last-minute bid to delay an upcoming trial in a class action lawsuit claiming it suppressed generic competition for its ulcerative colitis drug Asacol.

U.S. District Judge Denise Casper in Boston denied Allergan’s request to stay the case pending its appeal of her November 2017 decision to certify a class of health plans and other indirect purchasers of the drugs.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2DPH3to

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below